查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1298859

体外大肠癌筛查测试市场：2023-2028年全球行业趋势、份额、规模、增长、机会和预测

In-vitro Colorectal Cancer Screening Tests Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日期: | 出版商: IMARC | 英文 150 Pages | 商品交期: 2-3个工作天内

价格

2022年，全球体外结直肠癌筛查测试市场规模达到9.43亿美元。展望未来，IMARC集团预计，到2028年，市场规模将达到13.52亿美元，在2023-2028年期间呈现5.8%的增长率（CAGR）。

体外结直肠癌筛查试验是为检测腺瘤、息肉和结直肠癌症状而进行的诊断程序。大肠癌是指一种以大肠、结肠和直肠细胞异常生长为特征的医学症状。粪便隐血（FOB）、侧向流免疫、转铁蛋白检测、甲基化基因、生物标志物和guaiac FOB粪便检测是一些通常进行的筛查测试。体外结直肠癌筛查测试涉及到使用摄像头捕捉消化道的图像，并将其传输到绑在病人腰部的记录器。它们是微创性的，可以帮助及时发现癌症。因此，体外大肠癌筛查试验在诊所、医院和诊断实验室广泛开展。

体外结直肠癌筛查测试的市场趋势：

结直肠癌在群众中的发病率越来越高，这是推动市场增长的关键因素之一。此外，人们对早期发现和及时治疗癌症的好处的认识不断提高，对市场的增长产生了积极的影响。各种技术进步，如癌症筛查测试中的基因测试的整合，正在为市场增长提供推动力。这些测试有助于早期检测，制定治疗计划，防止癌细胞扩散，最大限度地减少相关疾病的风险。与此相应，越来越多的人倾向于采用微创（MI）诊断程序来检测结直肠癌，这有利于市场的增长。其他因素，包括老年人口的增加，更容易受到这种疾病的影响，医疗保健行业的显著改善，以及各种政府倡议的实施，强制癌症筛查测试，预计将推动市场的增长。

目录

第一章：前言

第二章：范围和方法

  • 研究的目标
  • 利益相关者
  • 数据来源
    • 主要来源
    • 二级来源
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章：执行摘要

第四章：简介

  • 概述
  • 主要行业趋势

第五章：全球体外大肠癌筛查测试市场

  • 市场概况
  • 市场表现
  • COVID-19的影响
  • 市场预测

第六章：按产品分類的市场

  • 粪便隐血试验
    • 市场趋势
    • 关键部分
      • 瓜亚克FOB粪便测试
      • 免疫性粪便凝集试验
      • 侧面流免疫-FOB测试
      • 免疫性FOB ELISA测试
    • 市场预测
  • 生物标志物测试
    • 市场趋势
    • 关键领域
      • 肿瘤M2-PK粪便测试
      • 转铁蛋白检测
    • 市场预测
  • CRC DNA筛查测试
    • 市场趋势
    • 关键领域
      • 甲基化基因检测
      • DNA小组测试
    • 市场预测

第7章 ：按成像类型分類的市场

  • 结肠镜检查
    • 市场趋势
    • 市场预测
  • 直肠镜检查
    • 市场趋势
    • 市场预测
  • CT扫描
    • 市场趋势
    • 市场预测
  • 超声波
    • 市场趋势
    • 市场预测
  • 核磁共振
    • 市场趋势
    • 市场预测
  • PET扫描
    • 市场趋势
    • 市场预测

第8章：按终端用户分類的市场

  • 医院
    • 市场趋势
    • 市场预测
  • 诊所
    • 市场趋势
    • 市场预测
  • 诊断实验室
    • 市场趋势
    • 市场预测
  • 其他
    • 市场趋势
    • 市场预测

第九章：按地区分類的市场

  • 北美洲
    • 美国
      • 市场趋势
      • 市场预测
    • 加拿大
      • 市场趋势
      • 市场预测
  • 亚太地区
    • 中国
      • 市场趋势
      • 市场预测
    • 日本
      • 市场趋势
      • 市场预测
    • 印度
      • 市场趋势
      • 市场预测
    • 韩国
      • 市场趋势
      • 市场预测
    • 澳大利亚
      • 市场趋势
      • 市场预测
    • 印尼
      • 市场趋势
      • 市场预测
    • 其他国家
      • 市场趋势
      • 市场预测
  • 欧洲
    • 德国
      • 市场趋势
      • 市场预测
    • 法国
      • 市场趋势
      • 市场预测
    • 英国
      • 市场趋势
      • 市场预测
    • 意大利
      • 市场趋势
      • 市场预测
    • 西班牙
      • 市场趋势
      • 市场预测
    • 俄罗斯
      • 市场趋势
      • 市场预测
    • 其他国家
      • 市场趋势
      • 市场预测
  • 拉丁美洲
    • 巴西
      • 市场趋势
      • 市场预测
    • 墨西哥
      • 市场趋势
      • 市场预测
    • 其他国家
      • 市场趋势
      • 市场预测
  • 中东和非洲
    • 市场趋势
    • 按国家分類的市场
    • 市场预测

第十章：SWOT分析

  • 概述
  • 优势
  • 劣势
  • 机会
  • 威胁

第十一章 ：价值链分析

第十二章 ：波特斯五力分析

  • 概述
  • 买方的讨价还价能力
  • 供应商的讨价还价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第十三章 ：价格分析

第十四章：竞争格局

  • 市场结构
  • 主要参与者
  • 主要参与者的概况
    • Beckman Coulter Inc. (Danaher Corporation)
    • Eiken Chemical Co. Ltd.
    • Epigenomics AG
    • Exact Sciences Corporation
    • Hemosure Inc.
    • Immunostics Inc. (Boditech Med Inc.)
    • Medline Industries LP
    • Merck KGaA
    • Qiagen N.V.
    • Quest Diagnostics Incorporated
    • R-Biopharm AG
    • Siemens AG
    • Sysmex Corporation
Product Code: SR112023A5383

The global in-vitro colorectal cancer screening tests market size reached US$ 943 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 1,352 Million by 2028, exhibiting a growth rate (CAGR) of 5.8% during 2023-2028.

In-vitro colorectal cancer screening tests are diagnostic procedures performed to detect adenomas, polyps and symptoms of colorectal cancer. Colorectal cancer refers to a medical condition that is characterized by the abnormal growth of cells in the large intestine, colon and rectum. Fecal occult blood (FOB), lateral flow immuno, transferrin assays, methylated gene, biomarker and guaiac FOB stool test are some of the commonly performed screening tests. In-vitro colorectal cancer screening tests involve the use of cameras that capture images of the digestive tract and transfers them to the recorder tied to the waist of the patient. They are minimally invasive and can aid in timely detection of cancer. As a result, in-vitro colorectal cancer screening tests are widely performed across clinics, hospitals and diagnostics laboratories.

In-Vitro Colorectal Cancer Screening Tests Market Trends:

The increasing prevalence of colorectal cancer among the masses is one of the key factors driving the growth of the market. Moreover, rising awareness regarding the benefits of early detection and timely treatment of cancer is positively impacting the market growth. Various technological advancements, such as the integration of genetic testing in cancer screening tests, are providing a thrust to the market growth. These tests aid in early detection, developing treatment plans, preventing the spread of cancerous cells and minimizing the risks of developing associated disorders. In line with this, the increasing preference for minimally invasive (MI) diagnostic procedures to detect colorectal cancer is favoring the market growth. Other factors, including rising geriatric populations, which is more susceptible to such ailments and significant improvements in the healthcare industry, along with the implementation of various government initiatives mandating cancer screening tests, are anticipated to drive the market toward growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global In-vitro colorectal cancer screening tests market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, imaging type and end user.

Breakup by Product:

Fecal Occult Blood Tests

Guaiac FOB Stool Test

Immuno-FOB Agglutination Test

Lateral Flow Immuno-FOB Test

Immuno-FOB ELISA Test

Biomarker Tests

Tumor M2-PK Stool Test

Transferrin Assays

CRC DNA Screening Tests

Methylated Gene Testing

Panel DNA Tests

Breakup by Imaging Type:

Colonoscopy

Proctoscopy

CT Scan

Ultrasound

MRI

PET Scan

Breakup by End User:

Hospitals

Clinics

Diagnostic Laboratories

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Beckman Coulter Inc. (Danaher Corporation), Eiken Chemical Co. Ltd., Epigenomics AG, Exact Sciences Corporation, Hemosure Inc., Immunostics Inc. (Boditech Med Inc.), Medline Industries LP, Merck KGaA, Qiagen N.V., Quest Diagnostics Incorporated, R-Biopharm AG, Siemens AG and Sysmex Corporation.

Key Questions Answered in This Report

1. What was the size of the global in-vitro colorectal cancer screening tests market in 2022?

2. What is the expected growth rate of the global in-vitro colorectal cancer screening tests market during 2023-2028?

3. What has been the impact of COVID-19 on the global in-vitro colorectal cancer screening tests market?

4. What are the key factors driving the global in-vitro colorectal cancer screening tests market?

5. What is the breakup of the global in-vitro colorectal cancer screening tests market based on the product?

6. What is the breakup of the global in-vitro colorectal cancer screening tests market based on the imaging type?

7. What is the breakup of the global in-vitro colorectal cancer screening tests market based on end user?

8. What are the key regions in the global in-vitro colorectal cancer screening tests market?

9. Who are the key players/companies in the global in-vitro colorectal cancer screening tests market?

Table of Contents

1   Preface

2   Scope and Methodology

  • 2.1  Objectives of the Study
  • 2.2  Stakeholders
  • 2.3  Data Sources
    • 2.3.1  Primary Sources
    • 2.3.2  Secondary Sources
  • 2.4  Market Estimation
    • 2.4.1  Bottom-Up Approach
    • 2.4.2  Top-Down Approach
  • 2.5  Forecasting Methodology

3   Executive Summary

4   Introduction

  • 4.1  Overview
  • 4.2  Key Industry Trends

5   Global In-vitro Colorectal Cancer Screening Tests Market

  • 5.1  Market Overview
  • 5.2  Market Performance
  • 5.3  Impact of COVID-19
  • 5.4  Market Forecast

6   Market Breakup by Product

  • 6.1  Fecal Occult Blood Tests
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Guaiac FOB Stool Test
      • 6.1.2.2 Immuno-FOB Agglutination Test
      • 6.1.2.3 Lateral Flow Immuno-FOB Test
      • 6.1.2.4 Immuno-FOB ELISA Test
    • 6.1.3 Market Forecast
  • 6.2  Biomarker Tests
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Tumor M2-PK Stool Test
      • 6.2.2.2 Transferrin Assays
    • 6.2.3 Market Forecast
  • 6.3  CRC DNA Screening Tests
    • 6.3.1 Market Trends
    • 6.3.2 Key Segments
      • 6.3.2.1 Methylated Gene Testing
      • 6.3.2.2 Panel DNA Tests
    • 6.3.3 Market Forecast

7   Market Breakup by Imaging Type

  • 7.1  Colonoscopy
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2  Proctoscopy
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3  CT Scan
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4  Ultrasound
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5  MRI
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6  PET Scan
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8   Market Breakup by End User

  • 8.1  Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2  Clinics
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3  Diagnostic Laboratories
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4  Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9   Market Breakup by Region

  • 9.1  North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2  Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3  Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4  Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5  Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10  SWOT Analysis

  • 10.1  Overview
  • 10.2  Strengths
  • 10.3  Weaknesses
  • 10.4  Opportunities
  • 10.5  Threats

11  Value Chain Analysis

12  Porters Five Forces Analysis

  • 12.1  Overview
  • 12.2  Bargaining Power of Buyers
  • 12.3  Bargaining Power of Suppliers
  • 12.4  Degree of Competition
  • 12.5  Threat of New Entrants
  • 12.6  Threat of Substitutes

13  Price Analysis

14  Competitive Landscape

  • 14.1  Market Structure
  • 14.2  Key Players
  • 14.3  Profiles of Key Players
    • 14.3.1  Beckman Coulter Inc. (Danaher Corporation)
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 SWOT Analysis
    • 14.3.2  Eiken Chemical Co. Ltd.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
    • 14.3.3  Epigenomics AG
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4  Exact Sciences Corporation
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5  Hemosure Inc.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6  Immunostics Inc. (Boditech Med Inc.)
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7  Medline Industries LP
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 SWOT Analysis
    • 14.3.8  Merck KGaA
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9  Qiagen N.V.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10  Quest Diagnostics Incorporated
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11  R-Biopharm AG
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
    • 14.3.12  Siemens AG
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
      • 14.3.12.4 SWOT Analysis
    • 14.3.13  Sysmex Corporation
      • 14.3.13.1 Company Overview
      • 14.3.13.2 Product Portfolio
      • 14.3.13.3 Financials
      • 14.3.13.4 SWOT Analysis

List of Figures

  • Figure 1: Global: In-vitro Colorectal Cancer Screening Tests Market: Major Drivers and Challenges
  • Figure 2: Global: In-vitro Colorectal Cancer Screening Tests Market: Sales Value (in Million US$), 2017-2022
  • Figure 3: Global: In-vitro Colorectal Cancer Screening Tests Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 4: Global: In-vitro Colorectal Cancer Screening Tests Market: Breakup by Product (in %), 2022
  • Figure 5: Global: In-vitro Colorectal Cancer Screening Tests Market: Breakup by Imaging Type (in %), 2022
  • Figure 6: Global: In-vitro Colorectal Cancer Screening Tests Market: Breakup by End User (in %), 2022
  • Figure 7: Global: In-vitro Colorectal Cancer Screening Tests Market: Breakup by Region (in %), 2022
  • Figure 8: Global: In-vitro Colorectal Cancer Screening Tests (Fecal Occult Blood Tests) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 9: Global: In-vitro Colorectal Cancer Screening Tests (Fecal Occult Blood Tests) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 10: Global: In-vitro Colorectal Cancer Screening Tests (Biomarker Tests) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: In-vitro Colorectal Cancer Screening Tests (Biomarker Tests) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: In-vitro Colorectal Cancer Screening Tests (CRC DNA Screening Tests) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: In-vitro Colorectal Cancer Screening Tests (CRC DNA Screening Tests) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: In-vitro Colorectal Cancer Screening Tests (Colonoscopy) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: In-vitro Colorectal Cancer Screening Tests (Colonoscopy) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: In-vitro Colorectal Cancer Screening Tests (Proctoscopy) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: In-vitro Colorectal Cancer Screening Tests (Proctoscopy) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Global: In-vitro Colorectal Cancer Screening Tests (CT Scan) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Global: In-vitro Colorectal Cancer Screening Tests (CT Scan) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Global: In-vitro Colorectal Cancer Screening Tests (Ultrasound) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Global: In-vitro Colorectal Cancer Screening Tests (Ultrasound) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: Global: In-vitro Colorectal Cancer Screening Tests (MRI) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: Global: In-vitro Colorectal Cancer Screening Tests (MRI) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: Global: In-vitro Colorectal Cancer Screening Tests (PET Scan) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: Global: In-vitro Colorectal Cancer Screening Tests (PET Scan) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: Global: In-vitro Colorectal Cancer Screening Tests (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: Global: In-vitro Colorectal Cancer Screening Tests (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: Global: In-vitro Colorectal Cancer Screening Tests (Clinics) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: Global: In-vitro Colorectal Cancer Screening Tests (Clinics) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: Global: In-vitro Colorectal Cancer Screening Tests (Diagnostic Laboratories) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: Global: In-vitro Colorectal Cancer Screening Tests (Diagnostic Laboratories) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: Global: In-vitro Colorectal Cancer Screening Tests (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: Global: In-vitro Colorectal Cancer Screening Tests (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 34: North America: In-vitro Colorectal Cancer Screening Tests Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 35: North America: In-vitro Colorectal Cancer Screening Tests Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: United States: In-vitro Colorectal Cancer Screening Tests Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: United States: In-vitro Colorectal Cancer Screening Tests Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 38: Canada: In-vitro Colorectal Cancer Screening Tests Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 39: Canada: In-vitro Colorectal Cancer Screening Tests Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 40: Asia-Pacific: In-vitro Colorectal Cancer Screening Tests Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 41: Asia-Pacific: In-vitro Colorectal Cancer Screening Tests Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 42: China: In-vitro Colorectal Cancer Screening Tests Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 43: China: In-vitro Colorectal Cancer Screening Tests Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 44: Japan: In-vitro Colorectal Cancer Screening Tests Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 45: Japan: In-vitro Colorectal Cancer Screening Tests Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: India: In-vitro Colorectal Cancer Screening Tests Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: India: In-vitro Colorectal Cancer Screening Tests Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 48: South Korea: In-vitro Colorectal Cancer Screening Tests Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 49: South Korea: In-vitro Colorectal Cancer Screening Tests Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 50: Australia: In-vitro Colorectal Cancer Screening Tests Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 51: Australia: In-vitro Colorectal Cancer Screening Tests Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: Indonesia: In-vitro Colorectal Cancer Screening Tests Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: Indonesia: In-vitro Colorectal Cancer Screening Tests Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: Others: In-vitro Colorectal Cancer Screening Tests Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: Others: In-vitro Colorectal Cancer Screening Tests Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 56: Europe: In-vitro Colorectal Cancer Screening Tests Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 57: Europe: In-vitro Colorectal Cancer Screening Tests Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 58: Germany: In-vitro Colorectal Cancer Screening Tests Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 59: Germany: In-vitro Colorectal Cancer Screening Tests Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 60: France: In-vitro Colorectal Cancer Screening Tests Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 61: France: In-vitro Colorectal Cancer Screening Tests Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 62: United Kingdom: In-vitro Colorectal Cancer Screening Tests Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 63: United Kingdom: In-vitro Colorectal Cancer Screening Tests Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 64: Italy: In-vitro Colorectal Cancer Screening Tests Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 65: Italy: In-vitro Colorectal Cancer Screening Tests Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: Spain: In-vitro Colorectal Cancer Screening Tests Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 67: Spain: In-vitro Colorectal Cancer Screening Tests Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: Russia: In-vitro Colorectal Cancer Screening Tests Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 69: Russia: In-vitro Colorectal Cancer Screening Tests Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 70: Others: In-vitro Colorectal Cancer Screening Tests Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 71: Others: In-vitro Colorectal Cancer Screening Tests Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 72: Latin America: In-vitro Colorectal Cancer Screening Tests Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 73: Latin America: In-vitro Colorectal Cancer Screening Tests Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 74: Brazil: In-vitro Colorectal Cancer Screening Tests Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 75: Brazil: In-vitro Colorectal Cancer Screening Tests Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 76: Mexico: In-vitro Colorectal Cancer Screening Tests Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 77: Mexico: In-vitro Colorectal Cancer Screening Tests Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 78: Others: In-vitro Colorectal Cancer Screening Tests Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 79: Others: In-vitro Colorectal Cancer Screening Tests Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 80: Middle East and Africa: In-vitro Colorectal Cancer Screening Tests Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 81: Middle East and Africa: In-vitro Colorectal Cancer Screening Tests Market: Breakup by Country (in %), 2022
  • Figure 82: Middle East and Africa: In-vitro Colorectal Cancer Screening Tests Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 83: Global: In-vitro Colorectal Cancer Screening Tests Industry: SWOT Analysis
  • Figure 84: Global: In-vitro Colorectal Cancer Screening Tests Industry: Value Chain Analysis
  • Figure 85: Global: In-vitro Colorectal Cancer Screening Tests Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: In-vitro Colorectal Cancer Screening Tests Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: In-vitro Colorectal Cancer Screening Tests Market Forecast: Breakup by Product (in Million US$), 2023-2028
  • Table 3: Global: In-vitro Colorectal Cancer Screening Tests Market Forecast: Breakup by Imaging Type (in Million US$), 2023-2028
  • Table 4: Global: In-vitro Colorectal Cancer Screening Tests Market Forecast: Breakup by End User (in Million US$), 2023-2028
  • Table 5: Global: In-vitro Colorectal Cancer Screening Tests Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 6: Global: In-vitro Colorectal Cancer Screening Tests Market: Competitive Structure
  • Table 7: Global: In-vitro Colorectal Cancer Screening Tests Market: Key Players